Targeting angiogenesis in oncology, ophthalmology and beyond
Karolinska Institutet · Massachusetts Institute of Technology · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
307
total citations
- FWCI
- 48.21
- Percentile
- 100%
- References
- 305
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- Medicine
- Bevacizumab
- Angiogenesis
- Clinical trial
- Drug development
- Pegaptanib
- Investigational Drugs
- Vascular endothelial growth factor
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.